Investigation of Detected by Recent Various Human Papillomavirus from General Hospital in Seoul Area
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
인간 유두종 바이러스(HPV)에 의한 감염은 자궁경부암의 원인이다. HPV DNA의 세포 검사에서의 변화는 향후 더 도전적으로 발전을 기대한다, HPV 유전자형의 감염에 대한 새로운 HPV의 DNA (22종) chip 검사는 최근 한국에서 많이 개발되었다. 이 연구의 목적은 서울 지역에서 HPV 감염의 빈도와 유전자형 분포를 알아보고자 하였다. 지난 2015년 한 해 동안 서울지역 종합병원 내원객을 대상으로 총 5,614 검체의 검사에서 HPV 유전자형은 1,596 (28.4%) 에서 검출되었다, 이중 한 종류의 유전자형은 가진 검체(n=831) 중고위험 HPV는 679 (42.5%), 저위험 HPV는 152 (9.5%)로 나타났다. 이중 자주 발견 유전자형은 HPV-16 (16.5%), 58 (15.2%), 52 (8.8%), 51 (7.1%), 56 (5.9%) 순이었다. 혼합 유전자형(n=219) 중2종(n=176, 11.0%), 3종(n=37, 5.9%), 4종(n=2, 0.1%)이 나타났다 이에 본 연구는 종합 병원 방문자의 HPV 감염을 조사하였다. 이러한 연구 결과는 HPV 전국적으로 분포 및 백신의 도입을 안내하는 데 이용될 수 있을 것으로 사료되며 진료에 중요한 정보를 제공하며 역학적 추가 연구가 요구된다.
Abstract
Human papillomavirus (HPV) infection is a necessary precondition of cervical cancer. A change from cytology to molecular HPV testing is, however, challenging. A new HPV DNA chip test for the infection of 22 HPV genotypes were developed in Korea. The purpose of this study was to investigate the prevalence and genotype distribution of HPV infection in the Seoul area. Over the last year, a total of 5,614 samples were tested. Using a chip test, HPV genotypes were detected in 1,596 (28.4%); of which, 679 (42.5%) were considered as high risk and low risk HPV were 152 (9.5%). 831 were single positive samples (n=1596). The most frequently found genotypes in all HPV-single positive samples (n=831) were HPV-16 (16.5%), 58 (15.2%), 52 (8.8%), 51 (7.1%) and 56 (5.9%). Mixed genotypes (n=219) were detected in 2 (n=176, 11.0%), 3 (n=37, 5.9%), and 4 (n=2, 0.1%) positive samples (n=1596). This study demonstrated that epidemical investigated HPV infection in patients of general hospital. These findings could be used to indicate a nationwide distribution of HPV and the adoption of vaccines. It is hoped that additional epidemiological research regarding the outcomes that are important to decision makers will be conducted.
참고문헌 (33)
- zur Hausen H, "Papillomaviruses in the causation of human cancers : a brief historical account", Virology, 384, pp.260~265 (2009)
- Burd EM, "Human papillomavirus and cervical cancer", Clin Microbiol Rev, 16, pp.1~17 (2003)
- Zheng ZM, "Papillomavirus genome structure, expression, and posttranscriptional regulation", Front Biosci, 11, pp.2286~2302 (2006)
- Castle PE, "Evidence for frequent regression of cervical intraepithelial neoplasia-grade2", Obstet Gynecol, 113, pp.18~25 (2009)
- Mustafa RA, "Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy", Int J Gynaecol Obstet, 132, pp.259~265 (2016)
- 김성현, "Human Papillomavirus Prevalence and Genotype Distribution in Normal and ASCUS Specimens: Comparison of a Reverse Blot Hybridization Assay with a DNA Chip Test", 대한의생명과학회지, 21(1), pp.32~39 (2015), 대한의생명과학회[DOI]
- 이동섭, "Human Papillomavirus Distribution among Women in Western Shandong Province, East China using Reverse Blot Hybridization Assay", 대한의생명과학회지, 21(2), pp.69~76 (2015), 대한의생명과학회[DOI]
- Santesso N, "World Health Organization Guidelines : Treatment of cervical intraepithelial neoplasia 2–3 and screen and treat strategies to prevent cervical cancer", Int J Gynecol Obstet, 132, pp.252~258 (2016)
- Doorbar J, "Molecular biology of human papillomavirus infection and cervical cancer", Clin Sci(Lond), 110, pp.525~541 (2006)
- Palefsky JM, "Molecular virology and epidemiology of human papillomavirus and cervical cancer", Cancer Epidemiol Biomarkers Prev, 4, pp.415~428 (1995)
- Dijkstra MG, "Brush based self-sampling in combination with GP5+", 6+-PCR-based hrHPV testing : high concordance with physician-taken cervical scrapes for HPV genotyping and detection of high-grade CIN, 2012, pp.54, 147~151
- Cobos C, "The role of human papilloma virus(HPV)infection in non-anogenital cancer and the promise of immunotherapy : a review", Int Rev Immunol, 33, pp.383~401 (2014)
- Sotlar K, "Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction", J Med Virol, 74, pp.107~116 (2004)
- Sotlar K, "Detection and typing of human papillomavirus by e6 nested multiplex PCR", J Clin Microbiol, 42, pp.3176~3184 (2004)
- Hill CS, "Molecular diagnostic testing for infectious diseases using TMA technology", Expert Rev Mol Diagn, 1, pp.445~455 (2001)
- Nelson NC, "Chemiluminescent DNA probes: a comparison of the acridinium ester and dioxetane detection systems and their use in clinical diagnostic assays", Clin Chim Acta, 194, pp.73~90 (1990)
- Coutlée F, "Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada", J Med Virol, 83, pp.1034~1041 (2011)
- Thibaudeau E, "HPV prevalence and prognostic value in a prospective cohort of 255 patients with locally advanced HNSCC:A single-centre experience", Int J Otolaryngol, 2013, pp.437815~ (2013)[DOI]
- Suthipintawong C, "Human papilloma virus prevalence, genotype distribution, and pattern of infection in Thai women", Asian Pac J Cancer Prev, 12, pp.853~856 (2011)
- Arbyn M, "Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?", Clin Microbiol Infect, 21, pp.817~826 (2015)
- Saslow D, "American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer", Am J Clin Pathol, 137, pp.516~542 (2012)
- Kroupis C, "Human papilloma virus(HPV)molecular diagnostics", Clin Chem Lab Med, 49, pp.1783~1799 (2011)
- Rebolj M, "Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytology", Gynecol Oncol, 135, pp.474~480 (2014)
- Senkomago V, "Comparison of urine specimen collection times and testing fractions for the detection of high-risk human papillomavirus and high-grade cervical precancer", J Clin Virol, 74, pp.26~31 (2016)
- Vorsters A, "Optimization of HPV DNA detection in urine by improving collection, storage, and extraction", Eur J Clin Microbiol Infect Dis, 33, pp.2005~2014 (2014)
- Chen J, "HPV-p53-miR-34a axis in HPV-associated cancers", Ann Transl Med, 3, pp.331~ (2015)[DOI]
- Lorincz AT, "Validation of a DNA methylation HPV triage classifier in a screening sample", Int J Cancer, 138, pp.2745~2751 (2016)
- Boers A, "Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2", 3, 2016, pp.8, 29~
- 이영주, "자궁경부의 파파니콜로 도말표본 검사와 유두종 바이러스DNA Chip Test의 관계", 대한임상검사과학회지, 43(1), pp.26~32 (2011), 대한임상검사과학회
- 이경옥, "Genotype Frequency of Human Papillomavirus Determined by PCR and DNA Sequencing in Korean Women", 대한임상검사과학회지, 38(2), pp.99~105 (2006), 대한임상검사과학회
- Pereira N, "Human papillomavirus infection, infertility, and assisted reproductive outcomes", J Pathog, 2015, pp.578423~ (2015)
- 박미숙, "세포학적 진단에 따른 인유두종 바이러스 유전자형의 분석", 대한임상검사과학회지, 47(1), pp.39~45 (2015), 대한임상검사과학회[DOI]
- Geehyuk Kim, "Human Papillomavirus Prevalence and Distribution according to Age among Korean and Chinese Women", 대한임상검사과학회지, 47(4), pp.259~266 (2015), 대한임상검사과학회
